ArticleResearch square2024
Immunogenicity and safety of inactivated SARS-CoV-2 vaccine (CoronaVac) using two-dose primary protocol in children and adolescents (Immunita-002, Brazil): A phase IV six-month follow up.
Camila Amormino Corsini et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.